Identificador para citar o enlazar este ítem: http://hdl.handle.net/20.500.13003/9949
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
Identificadores
ISSN: 1756-283X
eISSN: 1756-2848
WOS ID: 000478873800001
Scopus EID: 2-s2.0-85066879289
PMID: 31205485
Embase PUI: L627801194
Compartir
Estadísticas
Ver estadísticas de uso de este ítemMetadatos
Ver el registro Dublin Core del ítemAutor
Chaparro, Maria; Barreiro-de Acosta, Manuel; Manuel Benitez, Jose; Cabriada, Jose Luis; Jose Casanova, Maria; Ceballos, Daniel; Esteve, Maria; Fernandez, Hipolito; Ginard Vicens, Daniel ; Gomollon, Fernando; Lorente, Rufo; Nos, Pilar; Riestra, Sabino; Rivero, Montserrat; Robledo, Pilar; Rodriguez, Cristina; Sicilia, Beatriz; Torrella, Emilio; Garre, Ana; Garcia-Esquinas, Esther; Rodriguez-Artalejo, Fernando; Gisbert, Javier P.; EpidemIBD Study Grp GETECCUFecha de publicación
2019-05Tipo de documento
research articleCitación
Chaparro M, Barreiro-De Acosta M, Benitez JM, Cabriada JL, Casanova MJ, Ceballos D, et al. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. Ther Adv Gastroenterol. 2019 May;12:1-11.Resumen
Background: Inflammatory bowel disease (IBD) is associated with a considerable burden to the patient and society. However, current data on IBD incidence and burden are limited because of the paucity of nationwide epidemiological studies, heterogeneous designs, and a low number of participating centers and sample size. The EpidemIBD study is a large-scale investigation to provide an accurate assessment of the incidence of IBD in Spain, as well as treatment patterns and outcomes. Methods: This multicenter, population-based incidence cohort study included patients aged >18 years with IBD (Crohn's disease, ulcerative colitis, or unclassified IBD) diagnosed during 2017 in 108 hospitals in Spain, covering 50% of the Spanish population. Each participating patient will attend 10 clinic visits during 5 years of follow up. Demographic data, IBD characteristics and family history, complications, treatments, surgeries, and hospital admissions will be recorded. Results: The EpidemIBD study is the first large-scale nationwide study to investigate the incidence of IBD in Spain. Enrollment is now completed and 3627 patients are currently being followed up. Conclusions: The study has been designed to overcome many of the limitations of previous European studies into IBD incidence by prospectively recruiting a large number of patients from all regions of Spain. In addition to epidemiological information about the burden of IBD, the 5-year follow-up period will also provide information on treatment patterns, and the natural history and financial burden of IBD.
Versión del editor
https://dx.doi.org/10.1177/1756284819847034Colecciones de Docusalut en las que aparece este ítem
Hospital Universitario Son Espases - HUSE > Comunicación científicaInstituto de Investigación Sanitaria Islas Baleares - IDISBA > Comunicación científica